The Latin America, Middle East and Africa Kidney Function Tests Market is expected to witness market growth of 8.6% CAGR during the forecast period (2021-2027).
The increasing number of hospital visits owing to the growing awareness regarding CKD and its treatment is responsible for this massive growth. Additionally, the segment is expected to witness bright growth prospects due to the creation of advanced infrastructures across different regions, which assist in carrying out effective diagnostic procedures. Moreover, the growth of the segment is expected to be propelled by the supportive reimbursement policies along with the initiatives undertook by healthcare enterprises around the world to encourage the usage of sophisticated diagnostic tests.
According to recent studies, there is an adverse impact on kidney functioning among COVID-19 patients. As per the Diagnostic Systems, 2020, above 40% of COVID-19 hospitalized patients show indications of abnormal kidney function like hematuria or albuminuria. With the increment in the number of tests for COVID-19 around the globe, the kidney functions test market is expected to also witness a rising growth trajectory. Kidney function tests are considered as simple methods that majorly utilize either the blood or urine to help recognize problems with the kidney.
The rising demand for effective diagnosis of kidney diseases is the major factor that fuels the growth & demand of the kidney function test market across the world. Additionally, the rising occurrences of chronic kidney diseases around the globe and increasing awareness and supportive initiatives by private & public healthcare organizations for early and efficient diagnostic procedures are also supporting the growth of the global kidney function test market during the forecast period. Besides, many makers are aiming for technologically upgraded tests that offer early disease diagnostic, thereby fuelling the market growth.
The Hospitals market dominated the South Africa Kidney Function Tests Market by End-use in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $11.5 million by 2027. The Diagnostic Laboratories market is showcasing a CAGR of 8.7% during (2021 - 2027). The Research Laboratories and Institutes market is expected to witness a CAGR of 10.6% during (2021 - 2027).
Based on Product, the market is segmented into Clearance Test, Blood Tests, Urine Tests, Dilution & Concentration Tests, and Others. Based on End Use, the market is segmented into Hospitals, Diagnostic Laboratories, Research Laboratories and Institutes and others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens AG, Randox Laboratories Limited, Quest Diagnostics, Incorporated, Laboratory Corporation of America holdings, Sysmex Corporation, ACON Laboratories, Inc., and Nova Biomedical Corporation.
Scope of the Study
Market Segments covered in the Report:
By Product
By End Use
By Country
Companies Profiled
Unique Offerings from the Publisher
The increasing number of hospital visits owing to the growing awareness regarding CKD and its treatment is responsible for this massive growth. Additionally, the segment is expected to witness bright growth prospects due to the creation of advanced infrastructures across different regions, which assist in carrying out effective diagnostic procedures. Moreover, the growth of the segment is expected to be propelled by the supportive reimbursement policies along with the initiatives undertook by healthcare enterprises around the world to encourage the usage of sophisticated diagnostic tests.
According to recent studies, there is an adverse impact on kidney functioning among COVID-19 patients. As per the Diagnostic Systems, 2020, above 40% of COVID-19 hospitalized patients show indications of abnormal kidney function like hematuria or albuminuria. With the increment in the number of tests for COVID-19 around the globe, the kidney functions test market is expected to also witness a rising growth trajectory. Kidney function tests are considered as simple methods that majorly utilize either the blood or urine to help recognize problems with the kidney.
The rising demand for effective diagnosis of kidney diseases is the major factor that fuels the growth & demand of the kidney function test market across the world. Additionally, the rising occurrences of chronic kidney diseases around the globe and increasing awareness and supportive initiatives by private & public healthcare organizations for early and efficient diagnostic procedures are also supporting the growth of the global kidney function test market during the forecast period. Besides, many makers are aiming for technologically upgraded tests that offer early disease diagnostic, thereby fuelling the market growth.
The Hospitals market dominated the South Africa Kidney Function Tests Market by End-use in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $11.5 million by 2027. The Diagnostic Laboratories market is showcasing a CAGR of 8.7% during (2021 - 2027). The Research Laboratories and Institutes market is expected to witness a CAGR of 10.6% during (2021 - 2027).
Based on Product, the market is segmented into Clearance Test, Blood Tests, Urine Tests, Dilution & Concentration Tests, and Others. Based on End Use, the market is segmented into Hospitals, Diagnostic Laboratories, Research Laboratories and Institutes and others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens AG, Randox Laboratories Limited, Quest Diagnostics, Incorporated, Laboratory Corporation of America holdings, Sysmex Corporation, ACON Laboratories, Inc., and Nova Biomedical Corporation.
Scope of the Study
Market Segments covered in the Report:
By Product
- Clearance Test
- Blood Tests
- Urine Tests
- Dilution & Concentration Tests,
- Others
By End Use
- Hospitals
- Diagnostic Laboratories
- Research Laboratories and Institutes
- others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Abbott Laboratories
- Danaher Corporation
- F. Hoffmann-La Roche Ltd.
- Siemens AG
- Randox Laboratories Limited
- Quest Diagnostics, Incorporated
- Laboratory Corporation of America holdings
- Sysmex Corporation
- ACON Laboratories, Inc.
- Nova Biomedical Corporation
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. LAMEA Kidney Function Tests Market by Product
Chapter 5. LAMEA Kidney Function Tests Market by End-use
Chapter 6. LAMEA Kidney Function Tests Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Abbott Laboratories
- Danaher Corporation
- F. Hoffmann-La Roche Ltd.
- Siemens AG
- Randox Laboratories Limited
- Quest Diagnostics, Incorporated
- Laboratory Corporation of America holdings
- Sysmex Corporation
- ACON Laboratories, Inc.
- Nova Biomedical Corporation
Methodology
LOADING...
